Making the complex, simple:
A roadmap for your OSD journey

Uncover unique insights from global Pfizer OSD scientists and manufacturing experts on the challenges facing your journey to market.

Discover how to navigate these complexities with confidence to bring your product to patients on time, without delay.

Watch now

overlay image

Support your oral solid dose manufacturing, every step of the way

As a part of Pfizer and backed by industry-leading resources, we’re your dedicated and dependable oral solid dose manufacturer that is the right fit in all senses - from manufacturing scale to mindset. We get you.

Our oral solid dose manufacturing network includes sites in:

  • Germany (Freiburg)
  • Ireland (Newbridge) 
  • Italy (Ascoli)
  • Japan (Nagoya)

Let's collaborate

Made by an altogether different kind of CDMO

At Pfizer CentreOne, our open and collaborative approach combined with years of experience helps us support you in taking your compound from scale-up to commercial OSD manufacturing. We have integrated cGMP pilot facilities dedicated to process optimization, clinical drug manufacturing, and scale-up technology transfers that help us on our mission to deliver on what we promise.

Our goal is to always remain transparent, working with you to redesign and optimize your manufacturing processes wherever possible.

Whether you require clinical or commercial manufacturing; we’re dedicated to your product’s long-term success and work closely with you to help produce your products reliably and efficiently.

We deliver multi-product and high containment solutions and manufacturing technologies including:

  • OEL 1-5 engineering controls from 10,000 to 0.01 μg/m3 manufacturing with fully segregated suites for non-potent and highly potent (HPOSD) compounds
  • Specialized solid dose delivery technologies (e.g. active coating, laser drilling)
  • Complex processes (e.g. controlled drugs, multi-particulates low dose/high dose compounds)
  • Primary and secondary packaging, pouching, serialization, and aggregation
  • Advanced process capabilities (e.g. real time release testing)

Range of Services: Clinical Phases to Lifecycle Management

Clinical Phases

  • Development & manufacturing
  • Technical transfer
  • Formulation optimization
  • Scale-up/validation

Submission

  • CMC preparation
  • Final package
  • Pre-approval inspection

Launch

  • Drug to market
  • Production efficiency studies

Lifecycle Management

  • Cold-chain management
  • Supply/distribution
  • Drug delivery expansion

Drug Substance

Compound classifications

  • Highly active compounds 
  • Immunosuppressants 
  • Sensitizers 
  • Hormones 
  • Controlled drugs 
  • Cytostatics/Cytotoxics

Manufacturing capabilities

  • Dry granulation 
  • Roller compaction 
  • Wet granulation 
  • Fluid bed granulation 
  • High shear granulation 
  • Wet & dry milling 
  • Extrusion/Spheronization 
  • Hot melt extrusion 
  • Compression 
  • Encapsulation 
  • Film coating 
  • Sugar coating 
  • Active coating 
  • Solvent coating 
  • Fluid bed coating 
  • Branding/Printing 
  • Automated inspection 
  • Serialization

Delivery technologies

  • Capsules
    • Immediate-release 
    • Modified-release 
    • Powder-filled 
    • Pellet-filled 
  • Pellets
    • Immediate-release 
    • Modified-release 
    • Enteric-coated
  • Tablets
    • Immediate-release 
    • Modified-release 
    • Fast-dissolve 
    • Bi-layer 
    • Active-coated 
    • Sugar-coated 
    • Dual-active overcoat 
    • Laser tablet drilling 

Global supply chain services

  • Serialization/track-and-trace programs 
  • Primary and secondary packaging development 
  • On-site regulatory experts 
  • Gateway services for EU and Japanese markets, including quality release support and multi-lingual secondary packaging, labelling and package inserts 

Primary and secondary packaging

  • Packaging Centers of Excellence for bottle, blister and pouching 
  • Automated lines 
  • High-volume and flexible-run packaging 
  • OEB 1-5 (OEL 10,000-0.01 μg/m3) 
  • Cold-forming and thermoforming capability 
  • Containment control (i.e. packaging of hormone and highly potent products) 
  • Packaging on demand 
  • Humidity control 
  • State-of-the-art inspection technologies 
Let’s collaborate